Letters

Throughout the year, the AHA comments on a vast number of proposed and interim final rules put forth by the federal regulatory agencies. In addition, AHA communicates with federal legislators to convey the hospital field's position on potential legislative changes that would impact patients and patient care. Below are the most recent letters from the AHA to these bodies.

Latest

Jan 31, 2023
January 31, 2023 April Tabor Secretary Federal Trade Commission 600 Pennsylvania Avenue NW Suite CC-5610 (Annex C) Washington, DC 20580
Jan 30, 2023
AHA comments on the CMS’ Request for Information on Essential Health Benefits (EHB).
Jan 30, 2023
AHA comments on the CMS' proposed Notice of Benefit and Payment Parameters for 2024.
Jan 30, 2023
AHA provides feedback to the Senate on the Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) Act, and to support Congress’ continued efforts to transform health care through permanent telehealth reform.
Jan 30, 2023
AHA provides feedback on the Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) Act, and to support Congress’ continued efforts to transform health care through permanent telehealth reform
Jan 30, 2023
AHA comments proposed revisions to the regulations governing the confidentiality of substance use disorder (SUD) records, commonly known as 42 CFR Part 2 (“Part 2”).
Jan 26, 2023
AHA Comments on AHRQ’s Request for Information on Creating a National Health Care System Action Alliance to Advance Patient Safety, Dec. 12, 2022
Jan 3, 2023
The AHA appreciates the opportunity to share our comments and asks that commissioners consider the following issues before making their final payment update recommendations.
Dec 5, 2022
AHA expresses concern about the potential impact of H.R. 3648, the Equal Access to Green Cards for Legal Employment (EAGLE) Act of 2022